The New York Times @nytimes
The Food and Drug Administration has approved a Pfizer nasal spray for treatment of migraines that uses a different therapy from other nasal products on the market for severe headache pain, the company said on Friday. https://t.co/7eLERdE0o1 — PolitiTweet.org